Your browser doesn't support javascript.
loading
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Heimall, Jennifer; Puck, Jennifer; Buckley, Rebecca; Fleisher, Thomas A; Gennery, Andrew R; Neven, Benedicte; Slatter, Mary; Haddad, Elie; Notarangelo, Luigi D; Baker, K Scott; Dietz, Andrew C; Duncan, Christine; Pulsipher, Michael A; Cowan, Mort J.
Afiliación
  • Heimall J; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Puck J; Department of Pediatrics, Allergy, Immunology, and Blood and Marrow Transplant Division, University of California San Francisco, San Francisco, California.
  • Buckley R; Departments of Pediatrics and Immunology, Duke University Medical Center, Durham, North Carolina.
  • Fleisher TA; Department of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland.
  • Gennery AR; Department of Paediatric Immunology, Newcastle upon Tyne, United Kingdom Institute of Cellular Medicine, Newcastle upon Tyne University, United Kingdom.
  • Neven B; Department of Immunology, Bone Marrow Transplantation, Hopital Necker Enfants Malades, Paris, France.
  • Slatter M; Department of Paediatric Immunology, Newcastle upon Tyne, United Kingdom Institute of Cellular Medicine, Newcastle upon Tyne University, United Kingdom.
  • Haddad E; Department of Pediatrics, Department of Microbiology, Infection and Immunology, University of Montreal, CHU Sainte-Justine, Montreal, Quebec, Canada.
  • Notarangelo LD; Laboratory of Host Defenses, NIAID, National Institutes of Health, Bethesda, Maryland.
  • Baker KS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Dietz AC; Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California.
  • Duncan C; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
  • Pulsipher MA; Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California. Electronic address: mpulsipher@chla.usc.edu.
  • Cowan MJ; Department of Pediatrics, Allergy, Immunology, and Blood and Marrow Transplant Division, University of California San Francisco, San Francisco, California.
Biol Blood Marrow Transplant ; 23(3): 379-387, 2017 Mar.
Article en En | MEDLINE | ID: mdl-28068510
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Investigación / Inmunodeficiencia Combinada Grave / Trasplante de Células Madre Hematopoyéticas / Supervivencia de Injerto Tipo de estudio: Guideline Límite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Investigación / Inmunodeficiencia Combinada Grave / Trasplante de Células Madre Hematopoyéticas / Supervivencia de Injerto Tipo de estudio: Guideline Límite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2017 Tipo del documento: Article